DN is associated with multiple hazardous ambient factors such as high glucose, advanced glycation end products (AGEs), hypertension, and dyslipidemia, which can activate TGF-β signaling through TGF-β-dependent and independent mechanisms. This evidence concerns the gene TGFB1 and hypertensive disorder.